Literature DB >> 3067657

Inactivation of the Creutzfeldt-Jakob disease agent.

Y Tamai, F Taguchi, S Miura.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3067657     DOI： 10.1002/ana.410240326

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

Review 1.  The sclera, the prion, and the ophthalmologist.

Authors:  J S Mehta; W A Franks
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

2.  Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.

Authors:  F Taguchi; Y Tamai; K Uchida; R Kitajima; H Kojima; T Kawaguchi; Y Ohtani; S Miura
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue.

Authors:  A Di Martino; J Safar; M Ceroni; C J Gibbs
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies: memorandum from two WHO meetings.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

6.  Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie.

Authors:  D M Taylor; H Fraser; I McConnell; D A Brown; K L Brown; K A Lamza; G R Smith
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.